166 related articles for article (PubMed ID: 31397441)
21. Characterization of putative multidrug resistance transporters of the major facilitator-superfamily expressed in Salmonella Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; De Zorzi R; Mirza O; Walz T; Rahman M
J Infect Chemother; 2015 May; 21(5):357-62. PubMed ID: 25724589
[TBL] [Abstract][Full Text] [Related]
22. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
[TBL] [Abstract][Full Text] [Related]
23. Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.
Schuster S; Vavra M; Kern WV
Antimicrob Agents Chemother; 2016 Jul; 60(7):4315-23. PubMed ID: 27161641
[TBL] [Abstract][Full Text] [Related]
24. Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of
Atzori A; Malloci G; Cardamone F; Bosin A; Vargiu AV; Ruggerone P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013182
[TBL] [Abstract][Full Text] [Related]
25. RND efflux pumps: structural information translated into function and inhibition mechanisms.
Ruggerone P; Murakami S; Pos KM; Vargiu AV
Curr Top Med Chem; 2013; 13(24):3079-100. PubMed ID: 24200360
[TBL] [Abstract][Full Text] [Related]
26. Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB.
Bohnert JA; Schuster S; Seeger MA; Fähnrich E; Pos KM; Kern WV
J Bacteriol; 2008 Dec; 190(24):8225-9. PubMed ID: 18849422
[TBL] [Abstract][Full Text] [Related]
27. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
[TBL] [Abstract][Full Text] [Related]
28. Substrate-dependent dynamics of the multidrug efflux transporter AcrB of Escherichia coli.
Yamamoto K; Tamai R; Yamazaki M; Inaba T; Sowa Y; Kawagishi I
Sci Rep; 2016 Feb; 6():21909. PubMed ID: 26916090
[TBL] [Abstract][Full Text] [Related]
29. Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors.
Wang Y; Alenzy R; Song D; Liu X; Teng Y; Mowla R; Ma Y; Polyak SW; Venter H; Ma S
Eur J Med Chem; 2020 Jan; 186():111910. PubMed ID: 31801655
[TBL] [Abstract][Full Text] [Related]
30. New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon
Schuster S; Vavra M; Köser R; Rossen JWA; Kern WV
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33199388
[TBL] [Abstract][Full Text] [Related]
31. Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.
Kinana AD; Vargiu AV; Nikaido H
Biochemistry; 2013 Nov; 52(46):8342-51. PubMed ID: 24205856
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of carbapenem binding sites within the RND-transporter AcrB.
Atzori A; Malviya VN; Malloci G; Dreier J; Pos KM; Vargiu AV; Ruggerone P
Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):62-74. PubMed ID: 30416087
[TBL] [Abstract][Full Text] [Related]
33. Site-Directed Mutagenesis Reveals Crucial Residues in
Xu S; Chen G; Liu Z; Xu D; Wu Z; Li Z; Hong M
Microb Drug Resist; 2020 Jun; 26(6):550-560. PubMed ID: 31834851
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.
Malvacio I; Buonfiglio R; D'Atanasio N; Serra G; Bosin A; Di Giorgio FP; Ruggerone P; Ombrato R; Vargiu AV
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1397-1408. PubMed ID: 31075229
[TBL] [Abstract][Full Text] [Related]
35. Computer simulations suggest direct and stable tip to tip interaction between the outer membrane channel TolC and the isolated docking domain of the multidrug RND efflux transporter AcrB.
Schmidt TH; Raunest M; Fischer N; Reith D; Kandt C
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1419-26. PubMed ID: 27045078
[TBL] [Abstract][Full Text] [Related]
36. AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.
Hayashi K; Nakashima R; Sakurai K; Kitagawa K; Yamasaki S; Nishino K; Yamaguchi A
J Bacteriol; 2016 Jan; 198(2):332-42. PubMed ID: 26527645
[TBL] [Abstract][Full Text] [Related]
37. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
38. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
Zhou X; Jia F; Liu X; Wang Y
Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced conformational changes in multidrug efflux transporter AcrB from Haemophilus influenzae.
Dastidar V; Mao W; Lomovskaya O; Zgurskaya HI
J Bacteriol; 2007 Aug; 189(15):5550-8. PubMed ID: 17526713
[TBL] [Abstract][Full Text] [Related]
40. A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in
Tambat R; Mahey N; Chandal N; Verma DK; Jangra M; Thakur KG; Nandanwar H
ACS Infect Dis; 2022 Feb; 8(2):255-270. PubMed ID: 35045260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
